Norman Gitlin

9.1k total citations
87 papers, 2.3k citations indexed

About

Norman Gitlin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Norman Gitlin has authored 87 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hepatology, 31 papers in Epidemiology and 18 papers in Surgery. Recurrent topics in Norman Gitlin's work include Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (15 papers). Norman Gitlin is often cited by papers focused on Liver Disease Diagnosis and Treatment (23 papers), Hepatitis C virus research (21 papers) and Hepatitis B Virus Studies (15 papers). Norman Gitlin collaborates with scholars based in United States, United Kingdom and Spain. Norman Gitlin's co-authors include Mitchell L. Shiffman, Eugene R. Schiff, Sheila Sherlock, L Kreel, Ronald C. Silvestri, Gordon R. Grahame, K. Rajender Reddy, H.S. Williams, John L. Stauffer and Lewis T. Mann and has published in prestigious journals such as New England Journal of Medicine, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Norman Gitlin

82 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norman Gitlin United States 26 1.3k 1.3k 361 249 217 87 2.3k
Daniel S. Pratt United States 22 1.3k 0.9× 1.3k 1.0× 915 2.5× 371 1.5× 266 1.2× 55 2.8k
Caroline A. Riely United States 31 1.2k 0.9× 1.5k 1.1× 805 2.2× 112 0.4× 299 1.4× 89 3.2k
Yasuhiro Takikawa Japan 25 1.3k 0.9× 1.2k 0.9× 467 1.3× 154 0.6× 410 1.9× 121 2.4k
Antoni Mas Spain 32 2.4k 1.8× 2.0k 1.5× 1.0k 2.8× 134 0.5× 152 0.7× 83 3.3k
D. Robert Dufour United States 18 612 0.5× 717 0.5× 275 0.8× 88 0.4× 161 0.7× 38 1.7k
Stanley M. Cohen United States 17 647 0.5× 776 0.6× 350 1.0× 109 0.4× 116 0.5× 66 1.5k
E Juhl Denmark 27 1.4k 1.1× 1.8k 1.3× 649 1.8× 67 0.3× 132 0.6× 113 2.8k
Christine M. Hunt United States 28 1.3k 1.0× 1.5k 1.1× 310 0.9× 237 1.0× 228 1.1× 75 3.1k
Arie Regev United States 34 2.6k 1.9× 2.8k 2.1× 936 2.6× 302 1.2× 335 1.5× 95 4.7k
Agostino Colli Italy 31 2.2k 1.6× 2.8k 2.1× 1.0k 2.9× 159 0.6× 236 1.1× 87 3.9k

Countries citing papers authored by Norman Gitlin

Since Specialization
Citations

This map shows the geographic impact of Norman Gitlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norman Gitlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norman Gitlin more than expected).

Fields of papers citing papers by Norman Gitlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norman Gitlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norman Gitlin. The network helps show where Norman Gitlin may publish in the future.

Co-authorship network of co-authors of Norman Gitlin

This figure shows the co-authorship network connecting the top 25 collaborators of Norman Gitlin. A scholar is included among the top collaborators of Norman Gitlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norman Gitlin. Norman Gitlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barritt, A. Sidney, Norman Gitlin, Samuel Klein, et al.. (2017). Design and rationale for a real-world observational cohort of patients with nonalcoholic fatty liver disease: The TARGET-NASH study. Contemporary Clinical Trials. 61. 33–38. 39 indexed citations
2.
Kwo, Paul Y., Norman Gitlin, Ronald Nahass, et al.. (2016). Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study. PMC. 5 indexed citations
3.
Kowdley, Kris V., Daniel Nelson, Jacob Lalezari, et al.. (2015). P0829 : On-treatment HCVRNA as a predictor of sustained virologic response in HCV genotype 3 infected patients treated with daclatasvir and sofosbuvir: analysis of phase 3 ALLY-3 study. Journal of Hepatology. 62. S648–S648. 2 indexed citations
4.
Hassanein, Tarek, Karen Sims, Melanie E. Bennett, et al.. (2014). P1163 ALL-ORAL THERAPY WITH DACLATASVIR IN COMBINATION WITH ASUNAPREVIR AND BMS-791325 FOR TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE 4 INFECTION. Journal of Hepatology. 60(1). S472–S472. 9 indexed citations
5.
Reuben, Adrian & Norman Gitlin. (2011). Diagnosis and therapy of hepatocellular carcinoma : status quo and a glimpse at the future. Saunders eBooks. 1 indexed citations
6.
Tsai, Naoky & Norman Gitlin. (2010). Chronic hepatitis B : an update. Saunders eBooks. 1 indexed citations
7.
Marcellin, Patrick, et al.. (2009). Safety and efficacy of viramidine versus ribavirin in ViSER2: Randomized, double-blind study in therapy-naive hepatitis C patients. Journal of Hepatology. 52(1). 32–38. 33 indexed citations
8.
Chalasani, Naga & Norman Gitlin. (1997). TIPS for patients with refractory hepatic hydrothorax: what is the take-home message?. PubMed. 92(11). 2129–30. 6 indexed citations
9.
Chalasani, Naga & Norman Gitlin. (1997). Why do we need a newer generation of recombinant vaccines against hepatitis B?. PubMed. 92(12). 2314–5. 1 indexed citations
10.
Gitlin, Norman, et al.. (1992). Ischemic hepatitis: widening horizons.. PubMed. 87(7). 831–6. 83 indexed citations
11.
Gitlin, Norman. (1990). Ascitic Fluid Acidosis in Bacterial Peritonitis: A Poor Prognostic Sign?. Hepatology. 11(5). 896–898. 5 indexed citations
12.
Gitlin, Norman. (1988). Subclinical portal-systemic encephalopathy.. PubMed. 83(1). 8–11. 46 indexed citations
13.
Hudson, Donna L., et al.. (1987). Use of pattern-recognition techniques to analyze chromatographic data. Journal of Chromatography A. 384. 145–152. 6 indexed citations
14.
Cohen, Maurice E., et al.. (1985). Knowledge Represenation and Classification of Chromatographic Data for Diagnostic Medical Decision Making.. 481–486. 1 indexed citations
15.
Hudson, Donna L., et al.. (1984). Pattern Classification of Patients with Spontaneous Bacterial Peritonitis Using New Orthogonal Functions with Extensions to Higher Dimensions. PubMed Central. 112–115.
16.
Seggie, Janet, et al.. (1979). Patterns of hepatic injury induced by methyldopa.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(3). 75–83. 6 indexed citations
17.
Gitlin, Norman, et al.. (1977). Raised serum transaminase levels in patients with rheumatic fever treated with salicylates.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 51(20). 697–8. 2 indexed citations
18.
Gitlin, Norman. (1975). The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 49(51). 2115–7. 1 indexed citations
19.
Gitlin, Norman, Gordon R. Grahame, L Kreel, H.S. Williams, & Sheila Sherlock. (1970). Splenic Blood Flow and Resistance in Patients with Cirrhosis Before and After Portacaval Anastomoses. Gastroenterology. 59(2). 208–213. 47 indexed citations
20.
Gitlin, Norman. (1969). Zieve's syndrome and porphyrinuria in an alcoholic.. BMJ. 1(5636). 96–98. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026